follitropin alfa
UkraineDrugs containing this active substance
-
The drug is prescribed to women for ovulation stimulation (specifically in the case of polycystic ovary syndrome) or for follicle development during assisted reproductive technology procedures (e.g., IVF). In men, Bemfol is prescribed to stimulate spermatogenesis in certain hormonal disorders.
Form: solution for injection
Active substance Dosage follitropin alfa 600 IU (44 mcg)/ml ATC: G03GA05
-
The drug is used to stimulate follicle development in women (for example, in cases of anovulation or during assisted reproductive procedures) and to stimulate spermatogenesis in men with certain types of hypogonadism.
Form: solution for injection
Active substance Dosage follitropin alfa 600 IU (44 mcg)/ml ATC: G03GA05
-
The drug is prescribed to women for ovulation stimulation (specifically in polycystic ovary syndrome) and follicle development during assisted reproductive technology procedures (e.g., IVF). In men, Bemfola is prescribed to stimulate spermatogenesis in certain forms of hypogonadism.
Form: solution for injection
Active substance Dosage follitropin alfa 600 IU (44 mcg)/ml ATC: G03GA05
-
The drug is prescribed to women for ovulation stimulation (specifically in polycystic ovary syndrome) and follicle development during assisted reproductive procedures (e.g., IVF). In men, Bemfola is prescribed to stimulate sperm production in certain hormonal disorders.
Form: solution for injection
Active substance Dosage follitropin alfa 600 IU (44 mcg)/ml or 225 IU (16.5 mcg)/0.375 ml ATC: G03GA05
-
The drug is used to stimulate ovulation in women (specifically in cases of polycystic ovary syndrome or during assisted reproductive technology procedures) and to stimulate spermatogenesis in men with certain hormonal disorders.
Form: solution for injection
Active substance Dosage follitropin alfa 600 IU (44 mcg)/ml ATC: G03GA05
-
The drug is used for the treatment of infertility. In women, it is indicated for ovulation stimulation (specifically in polycystic ovary syndrome) and the development of multiple follicles during assisted reproductive technology procedures (e.g., IVF). In men, Foligraph is used to stimulate spermatogenesis in certain hormonal disorders.
Form: lyophilisate for solution for injection
Active substance Dosage follitropin alfa 75 IU ATC: G03GA05
Manufacturer: Bharat Serums and Vaccines Limited (Full cycle - manufacturing, packaging, quality control, batch release)
-
The drug is used for the treatment of infertility in women (in cases of anovulation, polycystic ovary syndrome, or during assisted reproductive technology procedures) and for the stimulation of spermatogenesis in men with certain hormonal disorders.
Form: powder for injection solution
Active substance Dosage follitropin alfa 75 IU or 5.5 mcg ATC: G03GA05
Manufacturer: Merck Serono S.A., branch in Obonne
-
The drug is used to treat infertility. In women, it is prescribed for anovulation (including polycystic ovary syndrome), to stimulate follicle development during assisted reproductive technology (ART) procedures, or in cases of severe hormone deficiency. In men, the drug is used to stimulate spermatogenesis in certain forms of hypogonadism.
Form: solution for injection
Active substance Dosage follitropin alfa 300 IU (22 mcg)/0.48 mL ATC: G03GA05
Manufacturer: Merck Serono S.p.A. (manufacturing of unpackaged drug, primary and secondary packaging, quality control and batch release)
-
The drug is used to treat infertility. In women, it is prescribed for the absence of ovulation (including polycystic ovary syndrome), to stimulate follicle development during assisted reproductive technology procedures (e.g., IVF), or in cases of severe hormone deficiency. In men, the drug is used to stimulate spermatogenesis in certain hormonal disorders.
Form: solution for injection
Active substance Dosage follitropin alfa 450 IU 33 mcg 0.72 mL ATC: G03GA05
Manufacturer: Merck Serono S.p.A. (manufacturing of unpackaged drug, primary and secondary packaging, quality control and batch release)
-
The drug is used to treat infertility. In women, it is intended for ovulation induction (specifically in cases of polycystic ovary syndrome) or follicle development during assisted reproductive technology (ART) procedures. In men, it is used to stimulate spermatogenesis in certain hormonal disorders.
Form: solution for injection
Active substance Dosage follitropin alfa 900 IU (66 mcg)/1.44 mL ATC: G03GA05
Manufacturer: Merck Serono S.p.A. (manufacturing of unpackaged drug, primary and secondary packaging, quality control and batch release)
-
The drug is used to stimulate follicle development in women with severe LH and FSH deficiency, as well as for controlled ovulation in women who have an inadequate response to other treatments during assisted reproductive technology procedures (e.g., IVF).
Form: powder and solvent for injection solution
Active substance Dosage follitropin alfa 150 IU lutropin alfa 75 IU ATC: G03GA30
Manufacturer: Merck Serono S.A., branch in Obonne